Guhan Pharmaceutical Group Co., Ltd.

¥7.86As of Sun 8 Nov 2026, 12:00 UTC
SZSE:000590Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR (9.46%)
Div yield —
ROE (10.60%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.31
PE TTM —
TSR TTM (37.42%)
Mkt cap ¥1.882B
ROIC (7.37%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥7.65
(2.70%)
(46.71%)
Sell 9|2|8|2|7
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.15
0.16
0.16
0.15
17.95%
19.41%
4.90%
(3.36%)
Revenue¥M
141.7
144.0
152.1
155.2
3.76%
4.84%
7.49%
9.08%
Peers (US$282.2M)
Cap (US$)
PE
281.3M
—
275.7M
29.33x
Capital
TTM
5Y
10Y
Leveragex
1.639
1.190
0.865
EBIT/Intx
1.194
0.416
0.451
Own earn%
(12.16)
12.12
11.60
Sh yield%
13.10
43.77
43.62
Owners
Insiders/Inst%
5.12
69.14
Short interest%
1.40
SBC / revenue%
4.05
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
8
Op margin range%
20–27
$1 testx
0.0
Incr. ROIC%
0